Clinical Trial Update: UCN-01 in Treating Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for UCN-01 in patients with advanced cancers. The study status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• UCN-01 (7-hydroxystaurosporine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED